KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001348911

SEC filings (opens in a new tab)

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

Q4 2024 vs. Q3 2024

How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of KALV: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	122	2	130	+10
Shares	48.4M	72.1K	55.2M	+6.85M (+14.2%)
Value	$561.0M	$846.3K	$467.4M	−$92.7M (−16.6%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to KALV in Q4 2024
Institution	Shares	Value	% of portfolio
Boxer Capital Management, LLC	1,590,000	$13.5M	1.15%
Octagon Capital Advisors LP	1,370,000	$11.6M	1.98%
StemPoint Capital LP	992,803	$8.41M	2.11%
Allostery Investments LP	479,100	$4.06M	7.97%
Walleye Capital LLC	267,743	$2.27M	0.02%
Susquehanna Fundamental Investments, LLC	80,319	$680.3K	0.01%
Hennion & Walsh Asset Management, Inc.	74,827	$633.8K	0.03%
Panagora Asset Management Inc	71,896	$609.0K	0.00%
Ameriprise Financial Inc	53,382	$452.1K	0.00%
Persistent Asset Partners Ltd	41,952	$373.8K	0.32%
XTX Topco Ltd	31,573	$267.4K	0.02%
ProShare Advisors LLC	11,906	$100.8K	0.00%
Nebula Research & Development LLC	11,579	$98.1K	0.01%
Syon Capital LLC	10,993	$93.1K	0.01%
Profund Advisors LLC	10,762	$91.2K	0.00%
Graham Capital Management, L.P.	10,479	$88.8K	0.00%
Algert Global LLC	10,360	$87.7K	0.00%
Martin Worley Group	10,168	$86.1K	0.05%
Police & Firemen's Retirement System of New Jersey	7,695	$65.2K	0.00%
Aquatic Capital Management LLC	5,188	$43.9K	0.00%
GF Fund Management Co. Ltd.	1,023	$8.66K	0.00%
Bryn Mawr Trust Co	415	$3.52K	0.00%
Versant Capital Management, Inc	166	$1.41K	0.00%
Caitong International Asset Management Co., Ltd	157	$1.33K	0.00%
Creative Planning	113	$957	0.00%
R Squared Ltd	110	$932	0.00%
SBI Securities Co., Ltd.	94	$796	0.00%
EverSource Wealth Advisors, LLC	21	$178	0.00%
IFP Advisors, Inc	4	$34	0.00%

Sold out (19)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of KALV in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Boxer Capital, LLC	1,590,000	$18.4M
MPM Oncology Impact Management LP	896,915	$10.4M
First Turn Management, LLC	355,000	$4.11M
Balyasny Asset Management LLC	26,968	$312.3K
Squarepoint Ops LLC	25,749	$298.2K
Connor, Clark & Lunn Investment Management Ltd.	22,949	$265.7K
Susquehanna Portfolio Strategies, LLC	18,338	$212.4K
Paloma Partners Management Co	17,924	$207.6K
Deerfield Management Company, L.P. (Series C)	13,255	$153.5K
AQR Capital Management LLC	12,354	$143.1K
Healthcare of Ontario Pension Plan Trust Fund	4,500	$52.1K
Venturi Wealth Management, LLC	410	$4.75K
nVerses Capital, LLC	200	$2.32K
Red Tortoise LLC	187	$2.17K
Bessemer Group Inc	45	$1.00K
Lindbrook Capital, LLC	39	$452
Creekmur Asset Management LLC	23	$266
Fortitude Family Office, LLC	3	$35
National Bank of Canada	1	$12

Not filed for Q4 2024 yet (2)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KALV in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
ClariVest Asset Management LLC	57,096	$672.6K
PEAK6 Investments LLC	15,000	$173.7K